CBFA2T3-GLIS2 AML, an extremely aggressive AML subtype occurring in very young children, has a poor prognosis, with 5-year OS ranging from 14% to 42% and 5-year EFS ranging from 8% to 33% [52]. The gene discussed is GLIS2; the disease is acute myeloid leukemia.